{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:32:43Z","timestamp":1790386363195,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jdcr.2019.07.020","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T23:08:26Z","timestamp":1571699306000},"page":"888-891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Dupilumab facial redness: Positive effect of itraconazole"],"prefix":"10.1016","volume":"5","author":[{"given":"Fleur S.A.","family":"de Beer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne S.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Haeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieneke","family":"Ariens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorien","family":"van der Schaft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijke R.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein S.","family":"de Bruin-Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2019.07.020_bib1","doi-asserted-by":"crossref","unstructured":"Waldman RA, Dewane M, Sloan SB, Grant-Kels JM. Characterizing dupilumab facial redness: a multi-institution retrospective chart review. J Am Acad Dermatol. doi: https:\/\/doi.org\/10.1016\/j.jaad.2019.07.031. In press.","DOI":"10.1016\/j.jaad.2019.07.031"},{"issue":"1","key":"10.1016\/j.jdcr.2019.07.020_bib2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaad.2008.07.058","article-title":"The role of Malassezia in atopic dermatitis affecting the head and neck of adults","volume":"60","author":"Darabi","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jdcr.2019.07.020_bib3","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1034\/j.1398-9995.2000.00782.x","article-title":"The relevance of skin prick tests for Pityrosporum ovale in patients with head and neck dermatitis","volume":"55","author":"Devos","year":"2000","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.jdcr.2019.07.020_bib4","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1365-2222.1992.tb02815.x","article-title":"IgE antibodies to Pityrosporum orbiculare and Staphylococcus aureus in patients with very high serum total IgE","volume":"22","author":"Nordvall","year":"1992","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.jdcr.2019.07.020_bib5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1034\/j.1398-9995.2001.056006512.x","article-title":"Systemic ketoconazole is an effective treatment of atopic dermatitis with IgE-mediated hypersensitivity to yeasts","volume":"56","author":"Lintu","year":"2001","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.jdcr.2019.07.020_bib6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1468-3083.2004.00963.x","article-title":"Treatment of head and neck dermatitis comparing itraconazole 200 mg and 400 mg daily for 1 week with placebo","volume":"18","author":"Svejgaard","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jdcr.2019.07.020_bib7","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jaad.2014.04.045","article-title":"A retrospective descriptive study of oral azole antifungal agents in patients with patch test-negative head and neck predominant atopic dermatitis","volume":"71","author":"Kaffenberger","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jdcr.2019.07.020_bib8","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1001\/jamadermatol.2019.0109","article-title":"Assessment of the development of new regional dermatoses in patients treated for atopic dermatitis with dupilumab","volume":"155","author":"Zhu","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"9","key":"10.1016\/j.jdcr.2019.07.020_bib9","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jdcr.2018.08.027","article-title":"The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy","volume":"4","author":"Suresh","year":"2018","journal-title":"JAAD Case Rep"},{"issue":"7","key":"10.1016\/j.jdcr.2019.07.020_bib10","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jdcr.2018.05.014","article-title":"Erythrodermic presentation of psoriasis in a patient treated with dupilumab","volume":"4","author":"Tracey","year":"2018","journal-title":"JAAD Case Rep"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512619304047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512619304047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:20:38Z","timestamp":1762474838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512619304047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S2352512619304047"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2019.07.020","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dupilumab facial redness: Positive effect of itraconazole","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2019.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}